Case File
efta-02481223DOJ Data Set 11OtherEFTA02481223
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02481223
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Lawrence H. Summers
Sent:
Tuesday, November 10, 2015 3:30 PM
To:
Jeffrey Epstein
Cc:
Ihsoffice
Subject:
Fwd: Kazakhstan Macro Flash: A collapse in tenge REER to improve competitiveness -
1 page(s)
They r a mess
Sent from my iPhone
Please direct all scheduling inquiries to my office at:
Follow me on=twitter @Ihsummers
www.larrysummers.com<=a> <http://www.larrysummers.com/>
Begin forwarded message:
From: *Citi CEEMEA Economics <ceemea.economics@investmentresearch.citi.=om
<mailto:ceemea.econo=ics@investmentresearch.citi.com»
Date: November 10, 2015 at 10:08:32 AM EST
To:
cmailto
> Subject: Kazakhstan Macro Flash: A collapse in tenge REER to
impr=ve competitiveness - 1 page(s)
Reply-To: 'Citi CEEMEA Economics <ceemea.economics@investmentresearch.dti.c=m
<mailto:ceemea.econom=cs@investmentresearch.citi.com»
A=collapse in tenge REER signals improved competitiveness
Kazakhstan Macro Flash
•
Sep REER data reveals a collapse in tenge value against the currencies =f trading partners. After falling by 5.5% in
Aug, tenge's real effec=ive exchange rate (REER) dropped by 20.3% in Sep, hitting the levels seen =either at the depths
of 2008-2009 crisis nor after Feb 2014 devaluationn
•
As a result, REER is now signific=ntly below its long-term average, signaling a boost to Kazakhstan's =xternal
competitiveness.
•
Current REER levels support our view that no further significant c=rrency weakening is needed to bring the
exchange rate in line with fundame=tals. Even so, the lack of market confidence in tenge means that overshoot=ng is
still possible before the currency finds its equilibrium value.
Read Full Report
<https://www.citivelocity.com/rendition/eppublic/documentService/=XNIcl9p2D1lXzFxbktMZjIMRktTZkRKSEV3d0JR/ZG
EFTA_R1_01597571
EFTA02481223
9jX2IkPTYxNzY5MiZwdWJJZD0yNTgyNz=2.ImFzc2V0Q2xhc3M9RUNPTk9NSUNTLEVDT05PTUIDU19FTSZjaGFubmVsPURDT
SZzdWItY2hhb=5IbD1FbWFpbA>
ekaterina.vlasova@citi.com
<https://www.ci=ivelocity.com/rendition/eppublic/documentService/dXNIcl9p2D1IXzFxbktMZjIMR=tTZkRKSEV3d0JR/ZG
9jX2IkPTYxNzY5MiZjaGFubmVsPURDTSZzdWItY2hhbm5lbD1FbWFpbCZ=c6VuQXV0aG9yPXRydWUmYXV0aG9yTmFtZT1F
a2F0ZXJpbmEgVmxhc292YQ> I &n=sp; +7-495-643-1576 <tel:+7-495-643-1576>
Team Directory
<https://www.citivelocity.c=m/AnalystDirectory/eppublic/Home/AD/c29laWQ9ZXY1MTM4OQ%3D%3D>
<https://www.citivelocity=com/cv2/?focusirsearch>
<https://www.citivelocity.com/cv2/?focus=search>
chttps://www.citivelocity=com/cv2/?focus=search> chttps://www.citivelocity.com/cv2/?=ocus=search>
You received this email because you subscribed to the following: (Asset =lass/Type: Economics)
Manage
subscriptions <mailto:citirsch.subscriptions@citi.com?body=Ple=se discontinue the subscription.%0D%0A%0D%0A
[Asset Class/Type: Economicsl&subject=RE: Manage Subscription - A col=apse in tenge REER signals improved
competitiveness>
To ensure delivery, add 'ceemea.economics@investmentrese=rch.citi.com
<mailto:ce=mea.economics@investmentresearch.citi.com> ' to your address book. See instructions
chttps://www.citivelocity.com/Instructions/eppublic/Instructions/=nglish>
This was prepared fo
<mailto:
For analyst certific=tion, important disclosures, and non-US analyst disclosures relating to ex=erpts of research
already published, see the Disclosures section of the ex=erpted research report, which can be accessed via the hyperlink
provided.
Citi Research is a d=vision of Citigroup Global Markets Inc. (the "Firm"), which does=and seeks to do business
with companies covered in its research reports. A= a result, investors should be aware that the Firm may have a conflict
of interest that could affect the objectivity of =his report. Investors should consider this report as only a single factor =n
making their investment decision. Certain products (not inconsistent wit= the author's published research) are available
only on Citi's portals.
2
EFTA_R1_01597572
EFTA02481224
Technical Artifacts (16)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
ceemea.economics@investmentresearch.citiEmail
ceemea.economics@investmentresearch.dtiEmail
citirsch.subscriptions@citi.comEmail
cs@investmentresearch.citi.comEmail
ekaterina.vlasova@citi.comEmail
ics@investmentresearch.citi.comEmail
mea.economics@investmentresearch.citi.comPhone
+7-495-643-1576Phone
2481223Phone
2481224URL
http://www.larrysummers.comURL
https://www.ci=ivelocity.com/rendition/eppublic/documentService/dXNIcl9p2D1IXzFxbktMZjIMR=tTZkRKSEV3d0JR/ZGURL
https://www.citivelocity.c=m/AnalystDirectory/eppublic/Home/AD/c29laWQ9ZXY1MTM4OQ%3D%3DURL
https://www.citivelocity.com/cv2/?focus=searchURL
https://www.citivelocity.com/rendition/eppublic/documentService/=XNIcl9p2D1lXzFxbktMZjIMRktTZkRKSEV3d0JR/ZGURL
https://www.citivelocity=com/cv2/?focusirsearchRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.